Cancer Drug Discovery

Tumor Models in Cancer Research (Cancer Drug Discovery and Development) by Beverly A. Teicher

Tumor Models in Cancer Research (Cancer Drug Discovery and Development) by Beverly A. Teicher
Publisher: Humana Press; 1st edition (November 15, 2001) | ISBN: 0896038874 | Pages: 708 | PDF | 37.38 MB

"…the book synthesizes years of knowledge on all major models available for cancer research. As a first comprehensive summary on tumor models in many years, it is certainly a good reference to those working in preclinical and clinical cancer research and drug development." -Pharmaceutical Research "This publication belongs to the successful book series "Cancer Drug Discovery and Development™." The book provides an excellent guide over the experimental procedures developed in attempt to improve the treatment of malignancies. This publication represents an outstanding work devoted to the current state-of-the-art of the in vivo tumor models available for cancer research. The book will be of interest to oncologists, clinical and experimental cancer researchers. Practical approaches presented in the book, provide a guide to maximize the benefit for clinical anticancer treatment." - Neoplasma

Tumor Models in Cancer Research (Cancer Drug Discovery and Development)(Repost)  eBooks & eLearning

Posted by Nice_smile) at Feb. 7, 2017
Tumor Models in Cancer Research (Cancer Drug Discovery and Development)(Repost)

Tumor Models in Cancer Research (Cancer Drug Discovery and Development) by Beverly A. Teicher
English | 2011 | ISBN: 1607619679 | 693 Pages | PDF | 16.33 MB

Cancer Drug Discovery: Science and History (repost)  eBooks & eLearning

Posted by arundhati at Jan. 7, 2017
Cancer Drug Discovery: Science and History (repost)

Kim, K.-W., Roh, J.K., Wee, H.-J, "Cancer Drug Discovery: Science and History"
2017 | ISBN-10: 9402408428 | 276 pages | PDF | 10 MB
Ex Vivo Engineering of the Tumor Microenvironment (Cancer Drug Discovery and Development)

Ex Vivo Engineering of the Tumor Microenvironment (Cancer Drug Discovery and Development) by Aamir Aref
English | 28 Dec. 2016 | ISBN: 3319453955 | 148 Pages | PDF | 3.67 MB

This volume will outline how to recreate the tumor microenvironment, to culture primary tumors without the need for developmental priming factors, and to deliver targeted therapeutics in a manner that recapitulates pharmacokinetics in vivo. Much of what may be learned from this volume will aid in understanding many aspects of the enhanced study of tumor cell biology in a physiologic context.

Cancer Drug Discovery: Science and History  eBooks & eLearning

Posted by Underaglassmoon at Nov. 21, 2016
Cancer Drug Discovery: Science and History

Cancer Drug Discovery: Science and History
Springer | Cancer Research | December 13, 2016 | ISBN-10: 9402408428 | 276 pages | pdf | 9.96 mb

Authors: Kim, K.-W., Roh, J.K., Wee, H.-J., Kim, C.
Presents comprehensive charts of important discoveries of scientific endeavours on cancer research
Includes timelines and conceptual cartoons for wide spectrum of anticancer drugs
Provides a novel perspective for the research on cell network according to the systemic view of cancer

Gene Therapy for Cancer (Cancer Drug Discovery and Development)  eBooks & eLearning

Posted by alt_f4 at Sept. 9, 2015
Gene Therapy for Cancer (Cancer Drug Discovery and Development)

Gene Therapy for Cancer (Cancer Drug Discovery and Development) by Kelly K. Hunt
English | Feb. 2, 2007 | ISBN: 1588294722 | 483 Pages | PDF | 7.5 MB

The three sections of this volume present currently available cancer gene therapy techniques. Part I describes the various aspects of gene delivery. In Part II, the contributors discuss strategies and targets for the treatment of cancer.

Fluoropyrimidines in Cancer Therapy (Cancer Drug Discovery and Development)  eBooks & eLearning

Posted by alt_f4 at Sept. 9, 2015
Fluoropyrimidines in Cancer Therapy (Cancer Drug Discovery and Development)

Fluoropyrimidines in Cancer Therapy (Cancer Drug Discovery and Development) by Youcef M. Rustum
English | Dec. 2, 2002 | ISBN: 0896039560 | 340 Pages | PDF | 5 MB

Leading cancer researchers update and review the mechanisms of action and the therapeutic selectivity and efficacy of 5-FU with and without leucovorin and its prodrugs in the treatment of colorectal cancer. Among the combination agents considered are UFT/LV, 5-FU/EU, capecitabine (Xeloda), S-1, and a variety of thymidylate synthase inhibitors.
Hormone Therapy in Breast and Prostate Cancer (Cancer Drug Discovery and Development)

Hormone Therapy in Breast and Prostate Cancer (Cancer Drug Discovery and Development) by JORDAN V. CRAIG
English | Jan. 2, 2002 | ISBN: 0896036731 | 423 Pages | PDF | 5 MB

This book describes the principles underlying targeted hormonal treatments, assesses the actions of new and established agents, and illustrates the new applications of hormonal chemoprevention for breast cancer.

Death Receptors in Cancer Therapy (Cancer Drug Discovery and Development)  eBooks & eLearning

Posted by alt_f4 at Sept. 8, 2015
Death Receptors in Cancer Therapy (Cancer Drug Discovery and Development)

Death Receptors in Cancer Therapy (Cancer Drug Discovery and Development) by Wafik S. El-Deiry
English | Dec. 3, 2004 | ISBN: 1588291723 | 387 Pages | PDF | 7 MB

An in depth review of our latest understanding of the molecular events that regulate cell death and those molecules that provide targets for developing agonists or antagonists to modulate death signaling for therapeutic purposes.

Cell Cycle Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)  eBooks & eLearning

Posted by alt_f4 at Sept. 8, 2015
Cell Cycle Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)

Cell Cycle Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development) by Antonio Giordano
English | Nov. 20, 2002 | ISBN: 0896039307 | 327 Pages | PDF | 2.5 MB

Leading clinicians and investigators review in a comprehensible and user-friendly style all the latest information about the molecular biology of cell cycle control and demonstrate its clinical relevance to understanding neoplastic diseases.